0 Yorumlar
0 hisse senetleri
742 Gösterim
0 Yorumlar
Sponsorluk
Site içinde ara...
Yeni ruhlar keşfedin, yeni bağlantılar oluşturun ve yeni arkadaşlar edinin
-
Beğenmek, paylaşmak ve yorum yapmak için lütfen giriş yapın!
-
Alpha Emitter Market Demand Forecast, Cost Trends and Forecast to 2033Alpha Emitter Industry Insights: The “Global Alpha Emitter Market Professional Report 2025–2033” has been introduced by Straits Research to its research database. The report delivers a structured analysis covering market summary, product details, market size and share, value and volume metrics, segmentation, SWOT analysis, and key players, derived from rigorous...0 Yorumlar 0 hisse senetleri 486 Gösterim 0 Yorumlar
-
Alpha Emitters Market Gains Momentum with Advancements in Nuclear MedicineA new growth forecast report titled Alpha Emitters Market Share, Size, Trends, Industry Analysis Report, By Type of Radionuclide (Radium, Actinium, Lead, Bismuth, and Others); By Application; By Region; Segment Forecast, 2023- 2032 introduced by Polaris Market Research represents conclusive data on the overall market. It majorly targets to provide a detailed analysis of growth...0 Yorumlar 0 hisse senetleri 324 Gösterim 0 Yorumlar
-
Alpha-Emitter Radioligand Therapy Market OutlookThe global Alpha-Emitter Radioligand Therapy (α-RLT) market is at the forefront of a paradigm shift in oncology. Unlike traditional beta-emitters (like Lutetium-177), alpha-emitters deliver high-energy radiation over a much shorter range—typically just a few cell diameters—allowing for devastating "double-strand breaks" in cancer DNA while significantly sparing...0 Yorumlar 0 hisse senetleri 376 Gösterim 0 Yorumlar
-
Alpha-gal Syndrome Allergy Market Opportunity, Demand, recent trends, Major Driving Factors and Business Growth Strategies 2033· The Global Alpha-gal syndrome Allergy Market size was estimated at USD 80.02 million in 2026 and is projected to reach USD 149.98 million by 2033, growing with a CAGR of 12.43% from 2026-2033. With market research reports garnering immense significance in the speedily transforming market place, the team at Data Library Research...0 Yorumlar 0 hisse senetleri 25 Gösterim 0 Yorumlar
-
Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market : Key Drivers and Restraints 2025 –2032"Executive Summary Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market Value, Size, Share and Projections CAGR Value The Asia-Pacific alpha and beta emitters based radiopharmaceuticals market size was valued at USD 168.86 million in 2024 and is expected to reach USD 358.95 million by 2032, at a CAGR of 9.9% during the forecast...0 Yorumlar 0 hisse senetleri 1K Gösterim 0 Yorumlar
-
Middle East and Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market : Size, Share, and Future Growth 2025 –2032"Executive Summary: Middle East and Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market Size and Share by Application & Industry CAGR Value The Middle East and Africa alpha and beta emitters based radiopharmaceuticals market size was valued at USD 30.85 million in 2024 and is expected to reach USD 63.69 million by 2032, at a CAGR of...0 Yorumlar 0 hisse senetleri 972 Gösterim 0 Yorumlar
-
North America Alpha and Beta Emitters Based Radiopharmaceuticals Market : Size, Share, and Growth Opportunities 2025 –2032"Executive Summary North America Alpha and Beta Emitters Based Radiopharmaceuticals Market Size and Share Analysis Report CAGR Value The North America alpha and beta emitters based radiopharmaceuticals market size was valued at USD 339.33 million in 2024 and is expected to reach USD 783.52 million by 2032, at a CAGR of 11.1% during the forecast period...0 Yorumlar 0 hisse senetleri 983 Gösterim 0 Yorumlar
-
Biosimilars are eating Humira's lunch — and that's a good thingHumira's patent expired in 2016, but AbbVie fought off biosimilars for years. Now, the floodgates have opened. The US tumor necrosis factor alpha inhibitors market forecast shows that biosimilars will capture over 50% of the market by 2030, driving prices down. In 2023, the first biosimilar of Humira (Amjevita) launched at a 50% discount. That's huge for patients with high...0 Yorumlar 0 hisse senetleri 70 Gösterim 0 Yorumlar
-
Biosimilars are eating Humira's lunch — and that's good for patientsHumira (adalimumab) was a $20 billion drug — until biosimilars arrived in 2023. Now, prices have dropped by 50‑80%, making TNF inhibitors accessible to millions more patients. The TNF alpha inhibitors market forecast predicts that biosimilars will capture over 70% of the market by 2035. Why the shift? Because payers are forcing substitution, and patients are willing to...0 Yorumlar 0 hisse senetleri 73 Gösterim 0 Yorumlar
-
Higher Alpha Olefins Rising at 4.10% CAGR Through 2032 Polymer Building Blocks"Regional Overview of Executive Summary Higher Alpha Olefins Market by Size and Share The global higher alpha olefins market size was valued at USD 3.99 billion in 2024 and is expected to reach USD 5.50 billion by 2032, at a CAGR of 4.10% during the forecast period The strategies encompassed in the Higher Alpha Olefins report mainly include new product...0 Yorumlar 0 hisse senetleri 572 Gösterim 0 Yorumlar
-
Japan Alpha Lipoic Acid: A Powerful Antioxidant for Health and WellnessAlpha Lipoic Acid (ALA) is a naturally occurring compound that has gained global attention for its potent antioxidant properties and diverse health benefits. Known for combating oxidative stress and supporting metabolic functions, ALA is widely used in dietary supplements, functional foods, and pharmaceutical formulations. Japan, with its strong focus on nutraceuticals and health-conscious...0 Yorumlar 0 hisse senetleri 1K Gösterim 0 Yorumlar
-
Targeted Annihilation: The Science of Radioligand TherapyThe global Alpha-Emitter Radioligand Therapy (α-RLT) market is at the forefront of a paradigm shift in oncology. Unlike traditional beta-emitters (like Lutetium-177), alpha-emitters deliver high-energy radiation over a much shorter range—typically just a few cell diameters—allowing for devastating "double-strand breaks" in cancer DNA while significantly sparing...0 Yorumlar 0 hisse senetleri 484 Gösterim 0 Yorumlar
Daha Fazla Sonuç
Sponsorluk
Sponsorluk
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek